PubMed

Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ.

Ann Intern Med. 1998 Oct 15;129(8):597-604.PMID: 9786806 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.

Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ.

Ann Intern Med. 1996 Dec 1;125(11):891-900.PMID: 8967669 [PubMed - indexed for MEDLINE]Related articlesFree article

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Van de Werf F, Aylward PE, Topol EJ, et al.

Circulation. 1995 Nov 15;92(10):2811-8.PMID: 7586246 [PubMed - indexed for MEDLINE]Related articlesFree article

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.

Kase CS, O'Neal AM, Fisher M, Girgis GN, Ordia JI.

Ann Intern Med. 1990 Jan 1;112(1):17-21.PMID: 2104561 [PubMed - indexed for MEDLINE]Related articles

Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.

Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM.

Stroke. 2000 Aug;31(8):1802-11.PMID: 10926938 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.

Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al.

Neurology. 1995 Apr;45(4):649-58.PMID: 7723950 [PubMed - indexed for MEDLINE]Related articles

Cerebral venous congestion as indication for thrombolytic treatment.

Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.

Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87.PMID: 17573553 [PubMed - indexed for MEDLINE]Related articles

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E.

Circulation. 1998 Dec 22-29;98(25):2805-14.PMID: 9860780 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G.

N Engl J Med. 1992 Jul 2;327(1):1-6.PMID: 1598096 [PubMed - indexed for MEDLINE]Related articles

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.

Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM.

Am Heart J. 1999 Sep;138(3 Pt 1):493-9.PMID: 10467200 [PubMed - indexed for MEDLINE]Related articles

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

Van de Werf F, Barron HV, Armstrong PW, Granger CB, Berioli S, Barbash G, Pehrsson K, Verheugt FW, Meyer J, Betriu A, Califf RM, Li X, Fox NL; ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic.

Eur Heart J. 2001 Dec;22(24):2253-61.PMID: 11728145 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National Survey.

Tanne D, Gottlieb S, Caspi A, Hod H, Palant A, Reisin L, Rosenfeld T, Peled B, Marmor AT, Balkin J, Boyko V, Behar S.

Arch Intern Med. 1998 Mar 23;158(6):601-6.PMID: 9521224 [PubMed - indexed for MEDLINE]Related articlesFree article

Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results.

Selker HP, Beshansky JR, Schmid CH, Griffith JL, Longstreth WT Jr, O'Connor CM, Caplan LR, Massey EW, D'Agostino RB, Laks MM, et al.

Circulation. 1994 Oct;90(4):1657-61.PMID: 7923649 [PubMed - indexed for MEDLINE]Related articles

Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.

O'Connor CM, Califf RM, Massey EW, Mark DB, Kereiakes DJ, Candela RJ, Abbottsmith C, George B, Stack RS, Aronson L, et al.

J Am Coll Cardiol. 1990 Sep;16(3):533-40.PMID: 2117618 [PubMed - indexed for MEDLINE]Related articles

Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.

Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, White HD, Gore JM, Simoons ML, Weaver WD, Green CL, Topol EJ, Califf RM.

Circulation. 1998 Oct 6;98(14):1376-82.PMID: 9760291 [PubMed - indexed for MEDLINE]Related articlesFree article

Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction.

Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ.

Ann Intern Med. 1996 Feb 1;124(3):283-91.PMID: 8554222 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.

Zeymer U, Neuhaus KL.

Z Kardiol. 2000;89 Suppl 4:IV30-40. Review.PMID: 10810775 [PubMed - indexed for MEDLINE]Related articles

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML.

Circulation. 1991 Feb;83(2):448-59.PMID: 1899364 [PubMed - indexed for MEDLINE]Related articles

Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

Harrington RA, Sane DC, Califf RM, Sigmon KN, Abbottsmith CW, Candela RJ, Lee KL, Topol EJ.

J Am Coll Cardiol. 1994 Mar 15;23(4):891-8.PMID: 8106694 [PubMed - indexed for MEDLINE]Related articles

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Barbash GI, White HD, Modan M, Van de Werf F.

J Am Coll Cardiol. 1993 Sep;22(3):707-13.PMID: 8354802 [PubMed - indexed for MEDLINE]Related articles